Publications

  1. Pakzad A, Cheung WK, Van Moorsel CHM, Quan K, Mogulkoc N, Bartholmai BJ, Van Es HW, Ezircan A, Van Beek F, Veltkamp M, Karwoski R, Peikert T, Clay RD, Foley F, Braun C, Savas R, Sudre C, Doel T, Alexander DC, Wijeratne P, Hawkes D, Hu Y, Hurst JR, Jacob J. Evaluation of automated airway morphological quantification for assessing fibrosing lung disease. Computer Methods in Biomechanics and Biomedical Engineering-Imaging and Visualization. 2024 Dec; 12 (1):2325361
  2. Varghese C, Johnson GB, Eiken PW, Edell ES, Specks U, Larson NB, Peikert T. A Retrospective Evaluation of the Treatment Effects of Rituximab in Patients with Progressive and Symptomatic Fibrosing Mediastinitis. Ann Am Thorac Soc. 2024 Nov; 21 (11):1533-1541
    View PubMed
  3. Blyth KG, Adusumilli PS, Astoul P, Darlison L, Lee YCG, Mansfield AS, Marciniak SJ, Maskell N, Panou V, Peikert T, Rahman NM, Zauderer MG, Sterman D, Fennell DA. Leveraging the pleural space for anticancer therapies in pleural mesothelioma. Lancet Respir Med. 2024 Jun; 12 (6):476-483 Epub 2024 May 10
    View PubMed
  4. Saddoughi SA, Powell C, Stroh GR, Rajagopalan S, Bartholmai BJ, Boland JM, Aubry MC, Harmsen WS, Blackmon SH, Cassivi SD, Nichols FC, Reisenauer JS, Shen KR, Mansfield AS, Maldonado F, Peikert T, Wigle DA. Long-Term Survival and CANARY-Based Artificial Intelligence for Multifocal Lung Adenocarcinoma Mayo Clin Proc: Digital Health. 2024; 2(1):44-52.
  5. Al-Ghoula F, Albitar HAH, Duke J, Peikert T, Edell E. Diagnostic Accuracy of Endobronchial Ultrasound in Patients with Multifocal Adenocarcinoma and Negative Positron Emission Tomography-computed Tomography. Ann Am Thorac Soc 2024 Feb; 21 (2):354-356
    View PubMed
  6. Marty PK, Pathakumari B, Cox TM, Van Keulen VP, Erskine CL, Shah M, Vadiyala M, Arias-Sanchez P, Karnakoti S, Pennington KM, Theel ES, Lindestam Arlehamn CS, Peikert T, Escalante P. Multiparameter immunoprofiling for the diagnosis and differentiation of progressive versus nonprogressive nontuberculous mycobacterial lung disease-A pilot study. PLoS One. 2024; 19 (4):e0301659 Epub 2024 Apr 19
    View PubMed
  7. Al-Ghoula F, Patel K, Falde S, Rajagopalan S, Bartholmai B, Maldonado F, Peikert T. Assessment of interobserver concordance in radiomic tools for lung nodule classification, with a focus on BRODERS and SILA. Sci Rep. 2023 Dec 8; 13 (1):21725 Epub 2023 Dec 08
    View PubMed
  8. Pathakumari B, Marty PK, Shah M, Van Keulen VP, Erskine CL, Block MS, Arias-Sanchez P, Escalante P, Peikert T. Convalescent Adaptive Immunity Is Highly Heterogenous after SARS-CoV-2 Infection. J Clin Med. 2023 Nov 16; 12 (22)
    View PubMed
  9. Paez R, Kammer MN, Tanner NT, Shojaee S, Heideman BE, Peikert T, Balbach ML, Iams WT, Ning B, Lenburg ME, Mallow C, Yarmus L, Fong KM, Deppen S, Grogan EL, Maldonado F. Update on Biomarkers for the Stratification of Indeterminate Pulmonary Nodules. Chest. 2023 Oct; 164 (4):1028-1041 Epub 2023 May 25
    View PubMed
  10. Martin MJ, Dulohery Scrodin MM, Edell ES, Aguirre EA, Rajagopalan S, Bartholmai BJ, Peikert T. Bronchoscopic Lung Volume Reduction: Highlighting the Patient Selection Process. Mayo Clin Proc. 2023 Sep; 98 (9):1347-1352
    View PubMed
  11. Kammer MN, Mori H, Rowe DJ, Chen SC, Vasiukov G, Atwater T, Senosain MF, Antic S, Zou Y, Chen H, Peikert T, Deppen S, Grogan EL, Massion PP, Dubinett S, Lenburg M, Borowsky A, Maldonado F. Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma. JTO Clin Res Rep. 2023 Sep; 4 (9):100504 Epub 2023 Mar 23
    View PubMed
  12. Algarin-Perneth S, Suleiman R, Abeykoon JP, Halfdanarson T, Fuentes-Bayne HE, Yi JE, Peikert T, McGarrah PW. Deep and Repeated Response to Trastuzumab Deruxtecan in a Patient With Human Epidermal Growth Factor Receptor 2-Amplified Large-Cell Neuroendocrine Carcinoma With Brain Metastases: A Case Report. JCO Precis Oncol. 2023 Sep; 7:e2300242.
    View PubMed
  13. Escalante P, Vadiyala MR, Pathakumari B, Marty PK, Van Keulen VP, Hilgart HR, Meserve K, Theel ES, Peikert T, Bailey RC, Laniado-Laborin R. New diagnostics for the spectrum of asymptomatic TB: from infection to subclinical disease. Int J Tuberc Lung Dis. 2023 Jul 1; 27 (7):499-505
    View PubMed
  14. Simard T, Sarma D, Miranda WR, Jain CC, Anderson JH, Collins JD, El Sabbagh A, Jhand A, Peikert T, Reeder GS, Munger TM, Packer DL, Holmes DR. Pathogenesis, Evaluation, and Management of Pulmonary Vein Stenosis: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 Jun 20; 81(24):2361-2373.
    View PubMed
  15. Desai AP, Kosari F, Disselhorst M, Yin J, Agahi A, Peikert T, Udell J, Johnson SH, Smadbeck J, Murphy S, Karagouga G, McCune A, Schaefer-Klein J, Borad MJ, Cheville J, Vasmatzis G, Baas P, Mansfield A. Dynamics and survival associations of T cell receptor clusters in patients with pleural mesothelioma treated with immunotherapy. J Immunother Cancer. 2023 Jun; 11 (6)
    View PubMed
  16. Berti A, Hillion S, Konig MF, Moura MC, Hummel AM, Carmona E, Peikert T, Fervenza FC, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, Brunetta P, St Clair EW, Harris KM, Stone JH, Grandi G, Pers JO, Specks U, Cornec D. Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2023 May; 75(5):736-747. Epub 2023 Mar 15.
    View PubMed
  17. Paez R, Kammer MN, Balar A, Lakhani DA, Knight M, Rowe D, Xiao D, Heideman BE, Antic SL, Chen H, Chen SC, Peikert T, Sandler KL, Landman BA, Deppen SA, Grogan EL, Maldonado F. Longitudinal lung cancer prediction convolutional neural network model improves the classification of indeterminate pulmonary nodules. Sci Rep. 2023 Apr 15; 13 (1):6157
    View PubMed
  18. Berti A, Hillion S, Konig MF, Moura MC, Hummel AM, Carmona E, Peikert T, Fervenza FC, Kallenberg CGM, Langford CA, Merkel PA, Monach PA, Seo P, Spiera RF, Brunetta P, St Clair EW, Harris KM, Stone JH, Grandi G, Pers J, Specks U, Cornec D. Autoreactive plasmablasts after B cell depletion with rituximab and relapses in antineutrophil cytoplasmic antibody--associated vasculitis. Arthritis & Rheumatology. 2023; 75 (5):736-47
  19. Mudrick HE, Massey S, McGlinch EB, Parrett BJ, Hemsath JR, Barry ME, Rubin JD, Uzendu C, Hansen MJ, Erskine CL, Van Keulen VP, Drelich A, Panos JA, Fida M, Suh GA, Peikert T, Block MS, Tseng CK, Olivier GR, Barry MA. Comparison of replicating and nonreplicating vaccines against SARS-CoV-2. Sci Adv. 2022 Aug 26; 8 (34):eabm8563 Epub 2022 Aug 24
    View PubMed
  20. Luo YH, Liu H, Wampfler JA, Tazelaar HD, Li Y, Peikert T, Liu D, Leventakos K, Chen YM, Yang Y, Chiou SH, Yang P. Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation. J Cancer Res Clin Oncol. 2022 Aug; 148 (8):2099-2114 Epub 2021 Aug 26
    View PubMed
  21. Zauderer MG, Szlosarek PW, Le Moulec S, Popat S, Taylor P, Planchard D, Scherpereel A, Koczywas M, Forster M, Cameron RB, Peikert T, Argon EK, Michaud NR, Szanto A, Yang J, Chen Y, Kansra V, Agarwal S, Fennell DA. EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study. Lancet Oncol. 2022 Jun; 23 (6):758-767 Epub 2022 May 16
    View PubMed
  22. Kosari F, Disselhorst M, Yin J, Peikert T, Udell J, Johnson S, Smadbeck J, Murphy S, McCune A, Karagouga G, Desai A, Schaefer-Klein J, Borad MJ, Cheville J, Vasmatzis G, Baas P, Mansfield AS. Tumor Junction Burden and Antigen Presentation as Predictors of Survival in Mesothelioma Treated With Immune Checkpoint Inhibitors. J Thorac Oncol. 2022 Mar; 17 (3):446-454 Epub 2021 Nov 17
    View PubMed
  23. Baqir M, Peikert T, Johnson TF, Tandon YK, Yi ES, Schroeder DR, Ryu JH. Idiopathic chronic eosinophilic pneumonia evolving to pulmonary fibrosis: a retrospective analysis. Sarcoidosis Vasculitis and Diffuse Lung Diseases. 2022; 39 (2):e2022020
  24. Marty PK, Van Keulen VP, Erskine CL, Shah M, Hummel A, Stachowitz M, Fatis S, Granger D, Block MS, Duarte-Garcia A, Warrington KJ, Theel ES, Zhou X, Zeng H, Specks U, Escalante P, Peikert T. Antigen Specific Humoral and Cellular Immunity Following SARS-CoV-2 Vaccination in ANCA-Associated Vasculitis Patients Receiving B-Cell Depleting Therapy. Front Immunol. 2022; 13:834981 Epub 2022 Jan 28
    View PubMed
  25. Baqir M, Peikert T, Johnson TF, Tandon YK, Yi ES, Schroeder DR, Ryu JH. Idiopathic Chronic Eosinophilic Pneumonia Evolving to Pulmonary Fibrosis: A Retrospective Analysis. Sarcoidosis Vasc Diffuse Lung Dis. 2022; 39(2):e2022020. Epub 2022 Jun 29.
    View PubMed
  26. Berti A, Hillion S, Hummel AM, Son YM, Chriti N, Peikert T, Carmona EM, Abdulahad WH, Heeringa P, Harris KM, St Clair EW, Brunetta P, Fervenza FC, Langford CA, Kallenberg CG, Merkel PA, Monach PA, Seo P, Spiera RF, Stone JH, Grandi G, Sun J, Pers JO, Specks U, Cornec D, RAVE-ITN Research Group. Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis. JCI Insight. 2021 Nov 22; 6 (22)
    View PubMed
  27. Stroh GR, Peikert T, Escalante P. Active and latent tuberculosis infections in patients treated with immune checkpoint inhibitors in a non-endemic tuberculosis area. Cancer Immunol Immunother. 2021 Nov; 70 (11):3105-3111 Epub 2021 Mar 26
    View PubMed
  28. Robison HM, Chapman CA, Zhou H, Erskine CL, Theel E, Peikert T, Lindestam Arlehamn CS, Sette A, Bushell C, Welge M, Zhu R, Bailey RC, Escalante P. Risk assessment of latent tuberculosis infection through a multiplexed cytokine biosensor assay and machine learning feature selection. Sci Rep. 2021 Oct 15; 11 (1):20544
    View PubMed
  29. Ali MF, Egan AM, Shaughnessy GF, Anderson DK, Kottom TJ, Dasari H, Van Keulen VP, Aubry MC, Yi ES, Limper AH, Peikert T, Carmona EM. Antifibrotics Modify B-Cell-induced Fibroblast Migration and Activation in Patients with Idiopathic Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2021 Jun; 64(6):722-733.
    View PubMed
  30. Breen WG, Jeans EB, Gergelis KR, Garces YI, Park SS, Merrell KW, Peikert TD, Mansfield AS, Wigle DA, Harmsen WS, Ellerbusch DC, Olivier KR, John Lucido J, Owen D. Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity. Radiother Oncol. 2021 May; 158:246-252 Epub 2021 Mar 10
    View PubMed
  31. Maldonado F, Varghese C, Rajagopalan S, Duan F, Balar AB, Lakhani DA, Antic SL, Massion PP, Johnson TF, Karwoski RA, Robb RA, Bartholmai BJ, Peikert T. Validation of the BRODERS classifier (Benign versus aggRessive nODule Evaluation using Radiomic Stratification), a novel HRCT-based radiomic classifier for indeterminate pulmonary nodules. Eur Respir J. 2021 Apr; 57 (4) Epub 2021 Apr 01
    View PubMed
  32. Welby JP, Fender EA, Peikert T, Holmes DR Jr, Bjarnason H, Knavel-Koepsel EM. Evaluation of Outcomes Following Pulmonary Artery Stenting in Fibrosing Mediastinitis. Cardiovasc Intervent Radiol. 2021 Mar; 44 (3):384-391 Epub 2020 Nov 17
    View PubMed
  33. Lee J, Bartholmai B, Peikert T, Chun J, Kim H, Kim JS, Park SY. Evaluation of Computer-Aided Nodule Assessment and Risk Yield (CANARY) in Korean patients for prediction of invasiveness of ground-glass opacity nodule. PLoS One. 2021; 16 (6):e0253204 Epub 2021 June 14
    View PubMed
  34. Khawaja A, Bartholmai BJ, Rajagopalan S, Karwoski RA, Varghese C, Maldonado F, Peikert T. Do we need to see to believe?-radiomics for lung nodule classification and lung cancer risk stratification. J Thorac Dis. 2020 Jun; 12 (6):3303-3316
    View PubMed
  35. Peikert T, Bartholmai BJ, Maldonado F. Radiomics-based Management of Indeterminate Lung Nodules? Are We There Yet? Am J Respir Crit Care Med. 2020 May 8 Epub 2020 May 08
    View PubMed
  36. Breen WG, Garces YI, Olivier KR, Park SS, Merrell KW, Nichols FC, Peikert TD, Molina JR, Mansfield AS, Roden AC, Blackmon SH, Wigle DA. Surgery for Mesothelioma After Radiation Therapy (SMART); A Single Institution Experience. Front Oncol. 2020; 10:392 Epub 2020 Mar 24
    View PubMed
  37. Walsh M, Merkel PA, Peh CA, Szpirt WM, Puechal X, Fujimoto S, Hawley CM, Khalidi N, Flossmann O, Wald R, Girard LP, Levin A, Gregorini G, Harper L, Clark WF, Pagnoux C, Specks U, Smyth L, Tesar V, Ito-Ihara T, de Zoysa JR, Szczeklik W, Flores-Suarez LF, Carette S, Guillevin L, Pusey CD, Casian AL, Brezina B, Mazzetti A, McAlear CA, Broadhurst E, Reidlinger D, Mehta S, Ives N, Jayne DRW, PEXIVAS Investigators. Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis. N Engl J Med. 2020 Feb 13; 382 (7):622-631
    View PubMed
  38. Mansfield AS, Peikert T, Vasmatzis G. Chromosomal rearrangements and their neoantigenic potential in mesothelioma. Transl Lung Cancer Res. 2020 Feb; 9 (Suppl 1):S92-S99
    View PubMed
  39. Li C, Zhu B, Son YM, Wang Z, Jiang L, Xiang M, Ye Z, Beckermann KE, Wu Y, Jenkins JW, Siska PJ, Vincent BG, Prakash YS, Peikert T, Edelson BT, Taneja R, Kaplan MH, Rathmell JC, Dong H, Hitosugi T, Sun J. The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8(+) T Cell Fitness and Functionality. Immunity. 2020 Jan 14; 52 (1):201-202
    View PubMed
  40. Fender EA, Widmer RJ, Knavel Koepsel EM, Welby JP, Kern R, Peikert T, Bjarnason H, Holmes DR Jr. Catheter based treatments for fibrosing mediastinitis. Catheter Cardiovasc Interv. 2019 Nov 15; 94 (6):878-885 Epub 2019 Feb 21
    View PubMed
  41. Larsen BT, Chae JM, Dixit AS, Hartman TE, Peikert T, Roden AC. Clinical and Histopathologic Features of Immune Checkpoint Inhibitor-related Pneumonitis. Am J Surg Pathol. 2019 Oct; 43 (10):1331-1340
    View PubMed
  42. Tsao MS, Carbone M, Galateau-Salle F, Moreira AL, Nicholson AG, Roden AC, Adjei AA, Aubry MC, Fennell DA, Gomez D, Harpole D, Hesdorffer M, Hirsch FR, Liu G, Malik S, Nowak A, Peikert T, Salgia R, Szlosarek P, Taioli E, Yang H, Tsao A, Mansfield AS. Pathologic Considerations and Standardization in Mesothelioma Clinical Trials. J Thorac Oncol. 2019 Oct; 14 (10):1704-1717 Epub 2019 June 28
    View PubMed
  43. Gill RR, Tsao AS, Kindler HL, Richards WG, Armato SG 3rd, Francis RJ, Gomez DR, Dahlberg S, Rimner A, Simone CB 2nd, de Perrot M, Blumenthal G, Adjei AA, Bueno R, Harpole DH Jr, Hesdorffer M, Hirsch FR, Pass HI, Yorke E, Rosenzweig K, Burt B, Fennell DA, Lindwasser W, Malik S, Peikert T, Mansfield AS, Salgia R, Yang H, Rusch VW, Nowak AK. Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting. J Thorac Oncol. 2019 Oct; 14 (10):1718-1731 Epub 2019 Aug 27
    View PubMed
  44. Li C, Zhu B, Son YM, Wang Z, Jiang L, Xiang M, Ye Z, Beckermann KE, Wu Y, Jenkins JW, Siska PJ, Vincent BG, Prakash YS, Peikert T, Edelson BT, Taneja R, Kaplan MH, Rathmell JC, Dong H, Hitosugi T, Sun J. The Transcription Factor Bhlhe40 Programs Mitochondrial Regulation of Resident CD8(+) T Cell Fitness and Functionality. Immunity. 2019 Sep 17; 51 (3):491-507.e7
    View PubMed
  45. Sears CR, Peikert T, Possick JD, Naidoo J, Nishino M, Patel SP, Camus P, Gaga M, Garon EB, Gould MK, Limper AH, Montgrain PR, Travis WD, Rivera MP. Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2019 Sep 15; 200 (6):e31-e43
    View PubMed
  46. Russell SJ, Babovic-Vuksanovic D, Bexon A, Cattaneo R, Dingli D, Dispenzieri A, Deyle DR, Federspiel MJ, Fielding A, Galanis E, Lacy MQ, Leibovich BC, Liu MC, Munoz-Alia M, Miest TC, Molina JR, Mueller S, Okuno SH, Packiriswamy N, Peikert T, Raffel C, Van Rhee F, Ungerechts G, Young PR, Zhou Y, Peng KW. Oncolytic Measles Virotherapy and Opposition to Measles Vaccination. Mayo Clin Proc. 2019 Sep; 94 (9):1834-1839 Epub 2019 June 22
    View PubMed
  47. Murphy SJ, Harris FR, Kosari F, Barreto Siqueira Parrilha Terra S, Nasir A, Johnson SH, Serla V, Smadbeck JB, Halling GC, Karagouga G, Sukov WR, Leventakos K, Yang P, Peikert T, Mansfield AS, Wigle DA, Yi ES, Kipp BR, Vasmatzis G, Aubry MC. Using Genomics to Differentiate Multiple Primaries From Metastatic Lung Cancer. J Thorac Oncol. 2019 Sep; 14 (9):1567-1582 Epub 2019 May 16
    View PubMed
  48. Clay R, Bartholmai BJ, Zhou B, Karwoski R, Peikert T, Osborn T, Rajagopalan S, Kalra S, Zhang X. Assessment of Interstitial Lung Disease Using Lung Ultrasound Surface Wave Elastography: A Novel Technique With Clinicoradiologic Correlates. J Thorac Imaging. 2019 Sep; 34 (5):313-319
    View PubMed
  49. Jacob J, Bartholmai BJ, van Moorsel CHM, Rajagopalan S, Devaraj A, van Es HW, Moua T, van Beek FT, Clay R, Veltkamp M, Kokosi M, de Lauretis A, Judge EP, Jacob TM, Peikert T, Karwoski R, Maldonado F, Renzoni E, Maher TM, Altmann A, Wells AU. Longitudinal prediction of outcome in idiopathic pulmonary fibrosis using automated CT analysis. Eur Respir J 2019 Sep; 54 (3) Epub 2019 Sept 30
    View PubMed
  50. Varghese C, Rajagopalan S, Karwoski RA, Bartholmai BJ, Maldonado F, Boland JM, Peikert T. Computed Tomography-Based Score Indicative of Lung Cancer Aggression (SILA) Predicts the Degree of Histologic Tissue Invasion and Patient Survival in Lung Adenocarcinoma Spectrum. J Thorac Oncol. 2019 Aug; 14 (8):1419-1429 Epub 2019 May 04
    View PubMed
  51. Muppa P, Parrilha Terra SBS, Sharma A, Mansfield AS, Aubry MC, Bhinge K, Asiedu MK, de Andrade M, Janaki N, Murphy SJ, Nasir A, Van Keulen V, Vasmatzis G, Wigle DA, Yang P, Yi ES, Peikert T, Kosari F. Immune Cell Infiltration May Be a Key Determinant of Long-Term Survival in Small Cell Lung Cancer. J Thorac Oncol. 2019 Jul; 14 (7):1286-1295 Epub 2019 May 09
    View PubMed
  52. Koo CW, Lu A, Takahashi EA, Simmons CL, Geske JR, Wigle D, Peikert T. Can MRI contribute to pulmonary nodule analysis? J Magn Reson Imaging. 2019 Jun; 49 (7):e256-e264 Epub 2018 Dec 21
    View PubMed
  53. Mansfield AS, Peikert T, Smadbeck JB, Udell JBM, Garcia-Rivera E, Elsbernd L, Erskine CL, Van Keulen VP, Kosari F, Murphy SJ, Ren H, Serla VV, Schaefer Klein JL, Karagouga G, Harris FR, Sosa C, Johnson SH, Nevala W, Markovic SN, Bungum AO, Edell ES, Dong H, Cheville JC, Aubry MC, Jen J, Vasmatzis G. Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma. J Thorac Oncol. 2019 Feb; 14 (2):276-287 Epub 2018 Oct 10
    View PubMed
  54. Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH Jr, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak AK, Pass HI, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB 2nd, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SM. Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation. J Thorac Oncol. 2018 Nov; 13 (11):1655-1667 Epub 2018 Sept 25
    View PubMed
  55. Yi ES, Sekiguchi H, Peikert T, Ryu JH, Colby TV. Reprint of: Pathologic manifestations of Immunoglobulin(Ig)G4-related lung disease. Semin Diagn Pathol. 2018 Sep; 35 (5):347-351 Epub 2018 Sept 08
    View PubMed
  56. Mutti L, Peikert T, Robinson BWS, Scherpereel A, Tsao AS, de Perrot M, Woodard GA, Jablons DM, Wiens J, Hirsch FR, Yang H, Carbone M, Thomas A, Hassan R. Scientific Advances and New Frontiers in Mesothelioma Therapeutics. J Thorac Oncol. 2018 Sep; 13 (9):1269-1283
    View PubMed
  57. Mansfield AS, Peikert T, Vogelzang NJ, Symanowski JT. Effects of Reduction in Tumor Burden on Survival in Epithelioid Malignant Pleural Mesothelioma. Mayo Clin Proc. 2018 Aug; 93 (8):1026-1033 Epub 2018 May 24
    View PubMed
  58. Clay R, Rajagopalan S, Karwoski R, Maldonado F, Peikert T, Bartholmai B. Computer Aided Nodule Analysis and Risk Yield (CANARY) characterization of adenocarcinoma: radiologic biopsy, risk stratification and future directions. Transl Lung Cancer Res. 2018 Jun; 7 (3):313-326
    View PubMed
  59. McCambridge AJ, Napolitano A, Mansfield AS, Fennell DA, Sekido Y, Nowak AK, Reungwetwattana T, Mao W, Pass HI, Carbone M, Yang H, Peikert T. Progress in the Management of Malignant Pleural Mesothelioma in 2017. J Thorac Oncol. 2018 May; 13 (5):606-623 Epub 2018 Mar 08
    View PubMed
  60. Pillappa R, Maleszewski JJ, Sukov WR, Bedroske PP, Greipp PT, Boland JM, Yi ES, Peikert T, Aubry MC, Roden AC. Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma. Am J Surg Pathol. 2018 Feb; 42 (2):256-263
    View PubMed
  61. Nakajima EC, Frankland MP, Johnson TF, Antic SL, Chen H, Chen SC, Karwoski RA, Walker R, Landman BA, Clay RD, Bartholmai BJ, Rajagopalan S, Peikert T, Massion PP, Maldonado F. Assessing the inter-observer variability of Computer-Aided Nodule Assessment and Risk Yield (CANARY) to characterize lung adenocarcinomas. PLoS One. 2018; 13 (6):e0198118 Epub 2018 June 01
    View PubMed
  62. Peikert T, Duan F, Rajagopalan S, Karwoski RA, Clay R, Robb RA, Qin Z, Sicks J, Bartholmai BJ, Maldonado F. Novel high-resolution computed tomography-based radiomic classifier for screen-identified pulmonary nodules in the National Lung Screening Trial. PLoS One. 2018; 13 (5):e0196910 Epub 2018 May 14
    View PubMed
  63. Clay R, Kipp BR, Jenkins S, Karwoski RA, Maldonado F, Rajagopalan S, Voss JS, Bartholmai BJ, Aubry MC, Peikert T. Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas. Sci Rep. 2017 Dec 15; 7 (1):17620
    View PubMed
  64. Cornec D, Berti A, Hummel A, Peikert T, Pers JO, Specks U. Identification and phenotyping of circulating autoreactive proteinase 3-specific B cells in patients with PR3-ANCA associated vasculitis and healthy controls. J Autoimmun. 2017 Nov; 84:122-131 Epub 2017 Sept 01
    View PubMed
  65. Leventakos K, Peikert T, Midthun DE, Molina JR, Blackmon S, Nichols FC, Garces YI, Hallemeier CL, Murphy SJ, Vasmatzis G, Kratz SL, Holland WP, Thomas CF, Mullon JJ, Shen KR, Cassivi SD, Marks RS, Aubry MC, Adjei AA, Yang P, Allen MS, Edell ES, Wigle D, Mansfield AS. Management of Multifocal Lung Cancer: Results of a Survey. J Thorac Oncol. 2017 Sep; 12 (9):1398-1402 Epub 2017 June 03
    View PubMed
  66. Kern R, Peikert T, Edell E, Mullon J, Midthun D, Utz J, Maldonado F. Bronchoscopic Management of Airway Compression due to Fibrosing Mediastinitis. Ann Am Thorac Soc 2017 Aug; 14 (8):1353-1355
    View PubMed
  67. Ali MF, Dasari H, Van Keulen VP, Cornec D, Vasmatzis G, Peikert T, Carmona EM. Microbial Antigens Stimulate Metalloprotease-7 Secretion in Human B-Lymphocytes Using mTOR-Dependent and Independent Pathways. Sci Rep. 2017 Jun 20; 7 (1):3869 Epub 2017 June 20
    View PubMed
  68. Welch BT, Eiken PW, Atwell TD, Peikert T, Yi ES, Nichols F, Schmit GD. A Single-Institution Experience in Percutaneous Image-Guided Biopsy of Malignant Pleural Mesothelioma. Cardiovasc Intervent Radiol. 2017 Jun; 40 (6):860-863 Epub 2017 Jan 30
    View PubMed
  69. Bhinge K, Yang L, Terra S, Nasir A, Muppa P, Aubry MC, Yi J, Janaki N, Kovtun IV, Murphy SJ, Halling G, Rahi H, Mansfield A, de Andrade M, Yang P, Vasmatzis G, Peikert T, Kosari F. EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression. Oncotarget. 2017 Apr 18; 8 (16):27155-27165
    View PubMed
  70. Saeed AI, Qeadan F, Sood A, VanderJagt DJ, Mishra SI, Hill DA, Peikert T, Sopori ML. A novel cytokine profile associated with cancer metastasis to mediastinal and hilar lymph nodes identified using fine needle aspiration biopsy - A pilot study. Cytokine. 2017 Jan; 89:98-104 Epub 2016 Sept 03
    View PubMed
  71. Terra SBSP, Mansfield AS, Dong H, Peikert T, Roden AC. Temporal and spatial heterogeneity of programmed cell death 1-Ligand 1 expression in malignant mesothelioma. Oncoimmunology. 2017; 6 (11):e1356146 Epub 2017 July 27
    View PubMed
  72. Pennington K, Sasieta HC, Ramos GP, Erskine CL, Van Keulen VP, Peikert T, Escalante P. Flow Cytometric Immune Profiling in Infliximab-Associated Tuberculosis. Clin Med Insights Case Rep. 2017; 10:1179547617724776 Epub 2017 Aug 24
    View PubMed
  73. Kottschade L, Brys A, Peikert T, Ryder M, Raffals L, Brewer J, Mosca P, Markovic S, Midwest Melanoma Partnership. A multidisciplinary approach to toxicity management of modern immune checkpoint inhibitors in cancer therapy. Melanoma Res. 2016 Oct; 26 (5):469-80
    View PubMed
  74. Bois MC, Mansfield AS, Sukov WR, Jenkins SM, Moser JC, Sattler CA, Smith CY, Molina JR, Peikert T, Roden AC. c-Met expression and MET amplification in malignant pleural mesothelioma. Ann Diagn Pathol. 2016 Aug; 23:1-7 Epub 2016 Apr 30
    View PubMed
  75. Boland JM, Froemming AT, Wampfler JA, Maldonado F, Peikert T, Hyland C, de Andrade M, Aubry MC, Yang P, Yi ES. Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules. Hum Pathol. 2016 May; 51:41-50 Epub 2015 Dec 30
    View PubMed
  76. Mansfield AS, Murphy SJ, Peikert T, Yi ES, Vasmatzis G, Wigle DA, Aubry MC. Heterogeneity of Programmed Cell Death Ligand 1 Expression in Multifocal Lung Cancer. Clin Cancer Res. 2016 May 1; 22 (9):2177-82 Epub 2015 Dec 14
    View PubMed
  77. Foley F, Rajagopalan S, Raghunath SM, Boland JM, Karwoski RA, Maldonado F, Bartholmai BJ, Peikert T. Computer-Aided Nodule Assessment and Risk Yield Risk Management of Adenocarcinoma: The Future of Imaging? Semin Thorac Cardiovasc Surg. 2016 Spring; 28 (1):120-6 Epub 2016 Jan 08
    View PubMed
  78. Koo CW, White DB, Lingineni RK, Peikert T, McGee KP, Sigmund EE, Tsang V, Carter RE, Sykes AM. Magnetic Resonance Imaging of Part-solid Nodules: A Pilot Study. J Thorac Imaging. 2016 Jan; 31: (1)2-10.
    View PubMed
  79. Felts SJ, Van Keulen VP, Scheid AD, Allen KS, Bradshaw RK, Jen J, Peikert T, Middha S, Zhang Y, Block MS, Markovic SN, Pease LR. Gene expression patterns in CD4+ peripheral blood cells in healthy subjects and stage IV melanoma patients. Cancer Immunol Immunother. 2015 Nov; 64 (11):1437-47 Epub 2015 Aug 06
    View PubMed
  80. Maldonado F, Duan F, Raghunath SM, Rajagopalan S, Karwoski RA, Garg K, Greco E, Nath H, Robb RA, Bartholmai BJ, Peikert T. Noninvasive Computed Tomography-based Risk Stratification of Lung Adenocarcinomas in the National Lung Screening Trial. Am J Respir Crit Care Med. 2015 Sep 15; 192 (6):737-44
    View PubMed
  81. Escalante P, Peikert T, Van Keulen VP, Erskine CL, Bornhorst CL, Andrist BR, Mccoy K, Pease LR, Abraham RS, Knutson KL, Kita H, Schrum AG, Limper AH. Combinatorial immunoprofiling in latent tuberculosis infection. Toward better risk stratification American Journal of Respiratory & Critical Care Medicine. 2015 Sep 1; 192: (5)605-17.
  82. Moser JC, Peikert T, Roden AC, Midthun DE, Mansfield AS. Spontaneous Regression of Malignant Pleural Mesothelioma in a Patient with New-Onset Inflammatory Arthropathy. Ann Am Thorac Soc 2015 Sep; 12 (9):1416-7
    View PubMed
  83. Escalante P, Peikert T, Van Keulen VP, Erskine CL, Bornhorst CL, Andrist BR, McCoy K, Pease LR, Abraham RS, Knutson KL, Kita H, Schrum AG, Limper AH. Combinatorial Immunoprofiling in Latent Tuberculosis Infection. Toward Better Risk Stratification. Am J Respir Crit Care Med. 2015 Sep 1; 192 (5):605-17
    View PubMed
  84. Brinjikji W, Boland Froemming JM, Holland WP, Peikert T, Johnson GB. Unexpectedly fludeoxyglucose (18F) avid well-differentiated adenocarcinoma of the lung. J Thorac Oncol. 2015 Apr; 10 (4):719-20
    View PubMed
  85. Gustafson MP, Lin Y, Maas ML, Van Keulen VP, Johnston PB, Peikert T, Gastineau DA, Dietz AB. A method for identification and analysis of non-overlapping myeloid immunophenotypes in humans. PLoS One. 2015; 10(3):e0121546. Epub 2015 Mar 23.
    View PubMed
  86. Hoeppner LH, Wang Y, Sharma A, Javeed N, Van Keulen VP, Wang E, Yang P, Roden AC, Peikert T, Molina JR, Mukhopadhyay D. Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells. Mol Oncol. 2015 Jan; 9 (1):270-81 Epub 2014 Aug 30
    View PubMed
  87. Murphy SJ, Aubry MC, Harris FR, Halling GC, Johnson SH, Terra S, Drucker TM, Asiedu MK, Kipp BR, Yi ES, Peikert T, Yang P, Vasmatzis G, Wigle DA. Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer. J Clin Oncol. 2014 Dec 20; 32 (36):4050-8 Epub 2014 Nov 10
    View PubMed
  88. Asiedu MK, Thomas CF Jr, Tomaszek SC, Peikert T, Sanyal B, Sutor SL, Aubry MC, Li P, Wigle DA. Generation and sequencing of pulmonary carcinoid tumor cell lines. J Thorac Oncol. 2014 Dec; 9(12):1763-71.
    View PubMed
  89. Raghunath S, Maldonado F, Rajagopalan S, Karwoski RA, DePew ZS, Bartholmai BJ, Peikert T, Robb RA. Noninvasive risk stratification of lung adenocarcinoma using quantitative computed tomography. J Thorac Oncol. 2014 Nov; 9 (11):1698-703
    View PubMed
  90. Mansfield AS, Symanowski JT, Peikert T. Systematic review of response rates of sarcomatoid malignant pleural mesotheliomas in clinical trials. Lung Cancer. 2014 Nov; 86 (2):133-6 Epub 2014 Sept 01
    View PubMed
  91. Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CGM, St Clair EW, Tchao NK, Viviano L, Ding L, Ikle D, Villarreal M, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH. Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis & Rheumatology. 2014 Nov; 66(11):3151-9.
  92. Westerly BD, Johnson GB, Maldonado F, Utz JP, Specks U, Peikert T. Targeting B lymphocytes in progressive fibrosing mediastinitis. Am J Respir Crit Care Med 2014 Nov 1; 190 (9):1069-71
    View PubMed
  93. Mansfield AS, Roden AC, Peikert T, Sheinin YM, Harrington SM, Krco CJ, Dong H, Kwon ED. B7-H1 expression in malignant pleural mesothelioma is associated with sarcomatoid histology and poor prognosis. J Thorac Oncol. 2014 Jul; 9 (7):1036-1040
    View PubMed
  94. Murphy SJ, Wigle DA, Lima JF, Harris FR, Johnson SH, Halling G, Asiedu MK, Seto CT, Terra S, Kosari F, Peikert T, Yang P, Aubry MC, Vasmatzis G. Genomic rearrangements define lineage relationships between adjacent lepidic and invasive components in lung adenocarcinoma. Cancer Res. 2014 Jun 1; 74 (11):3157-67
    View PubMed
  95. Cartin-Ceba R, Peikert T, Ashrani A, Keogh K, Wylam ME, Ytterberg S, Specks U. Primary antiphospholipid syndrome-associated diffuse alveolar hemorrhage. Arthritis Care Res (Hoboken). 2014 Feb; 66(2):301-10.
    View PubMed
  96. Moua T, Zand L, Hartman RP, Hartman TE, Qin D, Peikert T, Qian Q. Radiologic and clinical bronchiectasis associated with autosomal dominant polycystic kidney disease. PLoS One. 2014; 9 (4):e93674 Epub 2014 Apr 18
    View PubMed
  97. Raghunath S, Rajagopalan S, Karwoski RA, Maldonado F, Peikert T, Moua T, Ryu JH, Bartholmai BJ, Robb RA. Quantitative stratification of diffuse parenchymal lung diseases. PLoS One. 2014; 9 (3):e93229 Epub 2014 Mar 27
    View PubMed
  98. Miloslavsky EM, Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Tchao NK, Viviano L, Ding L, Sejismundo LP, Mieras K, Ikle D, Jepson B, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Stone JH, Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research Group. Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2013 Sep; 65(9):2441-9.
    View PubMed
  99. Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Fessler BJ, Ding L, Viviano L, Tchao NK, Phippard DJ, Asare AL, Lim N, Ikle D, Jepson B, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh K, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Mueller M, Sejismundo LP, Mieras K, Stone JH, RAVE-ITN Research Group. Efficacy of remission-induction regimens for ANCA-associated vasculitis. N Engl J Med. 2013 Aug 1; 369 (5):417-27
    View PubMed
  100. Yadav H, Peikert T. 30-year-old woman with dyspnea, cough, hemoptysis, and a cavitary lung lesion. Mayo Clin Proc. 2013 Jul; 88(7):e65-70.
    View PubMed
  101. Bradshaw M, Mansfield A, Peikert T. The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion. Curr Oncol Rep. 2013 Jun; 15 (3):207-16
    View PubMed
  102. Maldonado F, Boland JM, Raghunath S, Aubry MC, Bartholmai BJ, Deandrade M, Hartman TE, Karwoski RA, Rajagopalan S, Sykes AM, Yang P, Yi ES, Robb RA, Peikert T. Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study. J Thorac Oncol. 2013 Apr; 8 (4):452-60
    View PubMed
  103. Cartin-Ceba R, Peikert T, Specks U. Pathogenesis of ANCA-associated vasculitis. Curr Rheumatol Rep. 2012 Dec; 14 (6):481-93
    View PubMed
  104. Yi ES, Sekiguchi H, Peikert T, Ryu JH, Colby TV. Pathologic manifestations of Immunoglobulin(Ig)G4-related lung disease. Semin Diagn Pathol. 2012 Nov; 29: (4)219-25.
    View PubMed
  105. Krause ML, Cartin-Ceba R, Specks U, Peikert T. Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am. 2012 Nov; 32 (4):587-600 Epub 2012 Sept 28
    View PubMed
  106. Cartin-Ceba R, Golbin JM, Keogh KA, Peikert T, Sanchez-Menendez M, Ytterberg SR, Fervenza FC, Specks U. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center. Arthritis Rheum. 2012 Nov; 64 (11):3770-8
    View PubMed
  107. Ryu JH, Horie R, Sekiguchi H, Peikert T, Yi ES. Spectrum of Disorders Associated with Elevated Serum IgG4 Levels Encountered in Clinical Practice. Int J Rheumatol. 2012; 2012:232960 Epub 2012 May 27
    View PubMed
  108. Peikert T, Shrestha B, Aubry MC, Colby TV, Ryu JH, Sekiguchi H, Smyrk TC, Specks U, Yi ES. Histopathologic Overlap between Fibrosing Mediastinitis and IgG4-Related Disease. Int J Rheumatol. 2012; 2012:207056 Epub 2012 May 10
    View PubMed
  109. Peikert T, Colby TV, Midthun DE, Pairolero PC, Edell ES, Schroeder DR, Specks U. Fibrosing mediastinitis: clinical presentation, therapeutic outcomes, and adaptive immune response. Medicine (Baltimore). 2011 Nov; 90 (6):412-423
    View PubMed
  110. Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U, RAVE-ITN Research Group. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010 Jul 15; 363(3):221-32.
    View PubMed
  111. Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears A, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U, WGET Research Group. Glycosylation of proteinase 3 (PR3) is not required for its reactivity with antineutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis. Clin Exp Rheumatol. 2009 Jan-Feb; 27 (1 Suppl 52):S45-52
    View PubMed
  112. Peikert T, Daniels CE, Beebe TJ, Meyer KC, Ryu JH, Interstitial Lung Diseases Network of the American College of Chest Physicians. Assessment of current practice in the diagnosis and therapy of idiopathic pulmonary fibrosis. Respir Med. 2008 Sep; 102 (9):1342-8 Epub 2008 July 14
    View PubMed
  113. Heckman KL, Radhakrishnan S, Peikert T, Iijima K, McGregor HC, Bell MP, Kita H, Pease LR. T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammation. Eur J Immunol. 2008 Sep; 38 (9):2464-74
    View PubMed
  114. Peikert T, Finkielman JD, Hummel AM, McKenney ME, Gregorini G, Trimarchi M, Specks U. Functional characterization of antineutrophil cytoplasmic antibodies in patients with cocaine-induced midline destructive lesions. Arthritis Rheum. 2008 May; 58 (5):1546-51
    View PubMed
  115. Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears AK, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U, WGET Research Group. Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis. Ann Intern Med. 2007 Nov 6; 147 (9):611-9
    View PubMed
  116. Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Homburger HA, Peikert T, Hoffman GS, Merkel PA, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Tibbs AK, Ytterberg SR, Stone JH, Specks U, WGET Research Group. ANCA are detectable in nearly all patients with active severe Wegener's granulomatosis. Am J Med. 2007 Jul; 120 (7):643.e9-14
    View PubMed
  117. Lee AS, Finkielman JD, Peikert T, Hummel AM, Viss MA, Jacob GL, Homburger HA, Specks U, Wegener's Granulomatosis Etanercept Trial Research Group. Agreement of anti-neutrophil cytoplasmic antibody measurements obtained from serum and plasma. Clin Exp Immunol. 2006 Oct; 146 (1):15-20
    View PubMed
  118. Peikert T, Specks U, Farver C, Erzurum SC, Comhair SA. Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis. Cancer Res. 2006 May 1; 66 (9):4693-700
    View PubMed
  119. Lee AS, Finkielman JD, Peikert T, Hummel AM, Viss MA, Specks U. A novel capture-ELISA for detection of anti-neutrophil cytoplasmic antibodies (ANCA) based on c-myc peptide recognition in carboxy-terminally tagged recombinant neutrophil serine proteases. J Immunol Methods. 2005 Dec 20; 307(1-2):62-72.
    View PubMed
  120. Peikert T, Rana S, Edell ES. Safety, diagnostic yield, and therapeutic implications of flexible bronchoscopy in patients with febrile neutropenia and pulmonary infiltrates. Mayo Clin Proc. 2005 Nov; 80(11):1414-20.
    View PubMed
  121. Peikert T, Gillespie DJ, Cassivi SD. Catamenial pneumothorax. Mayo Clin Proc. 2005 May; 80(5):677-80.
    View PubMed
  122. Peikert T, Tazelaar HD, Prakash UBS. Endobronchial cryptococcosis: case report and review of the literature. J Bronchology. 2005; 12:59-61.
  123. Peikert T, Goetze S, Ghaffari S. A rare cause of coronary obstruction and angina pectoris. Heart. 2003 Sep; 89(9):1120.
    View PubMed
  124. Peikert T, Asher CR, Griffin BP. Systolic ejection murmur presenting with dyspnea on exertion. Cleve Clin J Med. 2001 Sep; 68(9):809-14.
    View PubMed
  125. Sitka U, Tippmann M, Peikert T, Gall V. Hair cell function diagram in premature and mature newborn infants. Z Geburtshilfe Neonatol. 2000 Jan-Feb; 204(1):20-5.
    View PubMed